Jefferies Financial Group’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Jefferies Financial Group's ONC Position: Q3 2026 in Review
Jefferies Financial Group increased its BeOne Medicines (ONC) stake by 184% in Q3 2026, buying an estimated $4.04M and bringing the position to 18,200 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #971.
Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.3M in Q4 2023. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Jefferies Financial Group held 18,200 shares of BeOne Medicines worth $512K as of Q3 2026.
- Jefferies Financial Group bought 11,800 BeOne Medicines shares in Q3 2026, an estimated $4.04M.
- BeOne Medicines made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #971 holding.
- Jefferies Financial Group first reported a position in BeOne Medicines in Q3 2023 and has held it in 10 quarters since.
- Jefferies Financial Group's BeOne Medicines position peaked at $8.3M in Q4 2023.
- 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.